As of 2026-04-01, the Relative Valuation of Fate Therapeutics Inc (FATE) is (27.08) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.20 USD, the upside of Fate Therapeutics Inc based on Relative Valuation is -2357.1%.
The range of the Relative Valuation is (24.69) - (28.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.1x - 24.5x | 24.1x |
| Forward P/E multiples | 21.1x - 26.6x | 22.1x |
| Fair Price | (24.69) - (28.73) | (27.08) |
| Upside | -2157.7% - -2493.9% | -2357.1% |
| Date | P/E |
| 2026-03-31 | -1.05 |
| 2026-03-30 | -0.96 |
| 2026-03-27 | -1.00 |
| 2026-03-26 | -1.05 |
| 2026-03-25 | -1.04 |
| 2026-03-24 | -0.96 |
| 2026-03-23 | -0.98 |
| 2026-03-20 | -0.94 |
| 2026-03-19 | -0.92 |
| 2026-03-18 | -0.90 |
| 2026-03-17 | -0.96 |
| 2026-03-16 | -0.99 |
| 2026-03-13 | -1.00 |
| 2026-03-12 | -1.00 |
| 2026-03-11 | -1.05 |
| 2026-03-10 | -1.10 |
| 2026-03-09 | -1.13 |
| 2026-03-06 | -1.13 |
| 2026-03-05 | -1.18 |
| 2026-03-04 | -1.24 |
| 2026-03-03 | -1.17 |
| 2026-03-02 | -1.28 |
| 2026-02-27 | -1.26 |
| 2026-02-26 | -1.33 |
| 2026-02-25 | -1.26 |
| 2026-02-24 | -1.38 |
| 2026-02-23 | -1.29 |
| 2026-02-20 | -1.25 |
| 2026-02-19 | -1.19 |
| 2026-02-18 | -1.17 |
| 2026-02-17 | -1.14 |
| 2026-02-13 | -1.07 |
| 2026-02-12 | -1.02 |
| 2026-02-11 | -1.00 |
| 2026-02-10 | -0.93 |
| 2026-02-09 | -0.96 |
| 2026-02-06 | -0.97 |
| 2026-02-05 | -0.90 |
| 2026-02-04 | -0.98 |
| 2026-02-03 | -0.99 |
| 2026-02-02 | -1.05 |
| 2026-01-30 | -1.01 |
| 2026-01-29 | -1.01 |
| 2026-01-28 | -1.03 |
| 2026-01-27 | -1.12 |
| 2026-01-26 | -1.05 |
| 2026-01-23 | -1.03 |
| 2026-01-22 | -1.07 |
| 2026-01-21 | -1.01 |
| 2026-01-20 | -0.94 |